Literature DB >> 9071944

Endoscopic management of Mirizzi's syndrome.

R E England1, D F Martin.   

Abstract

BACKGROUND: The accepted management of Mirizzi's syndrome is surgical, but endoscopic and percutaneous management have been described. AIM: To review our experience of endoscopic intervention for Mirizzi's syndrome. PATIENTS AND METHODS: ERCP reports of patients presenting for endoscopic management of choledocholithiasis between March 1989 and June 1995 were reviewed. Those with cholangiographic evidence of Mirizzi's syndrome were selected for study. Patient records and cholangiograms were reviewed and follow up was recorded from the notes or by telephone contact with patients, their relatives, or doctors.
RESULTS: Twenty five patients had Mirizzi's syndrome. Sixteen were female and their median age was 67 years (range 28-91). Ten presented with painless jaundice, nine with painful jaundice, four with cholangitis, and two had pain as their only symptom. Twelve were referred for surgery and 11 of these had preliminary endoscopic therapy. Thirteen have been treated solely with endoscopic therapy. Treatment in this group was aimed at relieving jaundice and removing stones. Stones were completely removed in three patients. Nine patients have been treated with long term stents, and one awaits extracorporeal shockwave lithotripsy of the gall bladder. Complications of treatment occurred in four of 25 after ERCP.
CONCLUSIONS: Endoscopic treatment of Mirizzi's syndrome is effective as a temporising measure before surgery and can be definitive treatment for unsuitable surgical candidates.

Entities:  

Mesh:

Year:  1997        PMID: 9071944      PMCID: PMC1027061          DOI: 10.1136/gut.40.2.272

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Endoscopic diagnosis and treatment of Mirizzi's syndrome.

Authors:  R Delcenserie; J P Joly; J L Dupas
Journal:  J Clin Gastroenterol       Date:  1992-12       Impact factor: 3.062

2.  Endoscopic gallbladder catheterisation and extracorporeal shockwave lithotripsy in the management of Mirizzi's syndrome.

Authors:  D F Martin; D E Tweedle; P N Rao
Journal:  Endoscopy       Date:  1988-11       Impact factor: 10.093

3.  Percutaneous lithotripsy and endoprosthesis: a new treatment for obstructive jaundice in Mirizzi's syndrome.

Authors:  S R Cairns; G N Watson; W R Lees; P R Salmon
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-05

4.  Case report: Mirizzi syndrome--treatment with metallic endoprosthesis.

Authors:  A Adam; M E Roddie; I S Benjamin
Journal:  Clin Radiol       Date:  1993-09       Impact factor: 2.350

5.  Endoscopic drainage of the gallbladder in a septic variant of the Mirizzi syndrome.

Authors:  N Vakil; R Sawyer
Journal:  Gastrointest Endosc       Date:  1994 Mar-Apr       Impact factor: 9.427

6.  Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula.

Authors:  H U Baer; J B Matthews; W P Schweizer; P Gertsch; L H Blumgart
Journal:  Br J Surg       Date:  1990-07       Impact factor: 6.939

7.  Mirizzi syndrome and cholecystobiliary fistula: a unifying classification.

Authors:  A Csendes; J C Díaz; P Burdiles; F Maluenda; O Nava
Journal:  Br J Surg       Date:  1989-11       Impact factor: 6.939

8.  Endoscopic treatment of Mirizzi's syndrome.

Authors:  K F Binmoeller; F Thonke; N Soehendra
Journal:  Gastrointest Endosc       Date:  1993 Jul-Aug       Impact factor: 9.427

9.  Mirizzi syndrome.

Authors:  T C Bower; D M Nagorney
Journal:  HPB Surg       Date:  1988-09

Review 10.  Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients.

Authors:  J J Bergman; E A Rauws; J G Tijssen; G N Tytgat; K Huibregtse
Journal:  Gastrointest Endosc       Date:  1995-09       Impact factor: 9.427

View more
  31 in total

Review 1.  Laparoscopic exploration of common bile duct in difficult choledocholithiasis.

Authors:  C K Tai; C N Tang; J P Y Ha; C H Chau; W T Siu; M K W Li
Journal:  Surg Endosc       Date:  2004-04-21       Impact factor: 4.584

2.  Long-term follow-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome: an analysis of risk factors predicting stone recurrence.

Authors:  Toshio Tsuyuguchi; Yuji Sakai; Harutoshi Sugiyama; Takeshi Ishihara; Osamu Yokosuka
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

3.  Mirizzi's syndrome--results from a large western experience.

Authors:  D Gomez; S H Rahman; G J Toogood; K R Prasad; J P A Lodge; P J Guillou; K V Menon
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

4.  Mirizzi syndrome.

Authors:  Sushil K Ahlawat; Rohit Singhania; Firas H Al-Kawas
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

5.  Laparoscopic common bile duct exploration after failed endoscopic stone extraction.

Authors:  Constantine Karaliotas; George Sgourakis; Constantine Goumas; Nickolaos Papaioannou; Constantine Lilis; Emmanouel Leandros
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

6.  A Case of Type IV Cholecystobiliary Fistula.

Authors:  Sushil K Ahlawat; Rohit Singhania
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-12

Review 7.  Surgical Management of Bile Duct Strictures.

Authors:  Moshim Kukar; Neal Wilkinson
Journal:  Indian J Surg       Date:  2013-09-20       Impact factor: 0.656

8.  Feeling the Impact of Long-Term Total Parenteral Nutrition.

Authors:  Zachary M Sellers; Chad Thorson; Steven Co; Kurt B Schaberg; John A Kerner
Journal:  Dig Dis Sci       Date:  2017-04-28       Impact factor: 3.199

9.  Difficult bile duct stones.

Authors:  Lee McHenry; Glen Lehman
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

10.  Post-cholecystectomy Mirizzi's syndrome: magnetic resonance cholangiopancreatography demonstration.

Authors:  Nisar A Wani; Naseer A Khan; Asif I Shah; Abdul Q Khan
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.